Janux Therapeutics, Inc. (JANX)
16.30
-0.38
(-2.28%)
USD |
NASDAQ |
Sep 25, 16:00
16.27
-0.03
(-0.18%)
After-Hours: 19:59
Janux Therapeutics Price to Book Value : 1.073 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 1.073 |
| September 24, 2026 | 1.098 |
| September 23, 2026 | 1.087 |
| September 22, 2026 | 1.150 |
| September 21, 2026 | 1.120 |
| September 18, 2026 | 1.092 |
| September 17, 2026 | 1.110 |
| September 16, 2026 | 1.069 |
| September 15, 2026 | 1.082 |
| September 14, 2026 | 1.139 |
| September 11, 2026 | 1.126 |
| September 10, 2026 | 1.164 |
| September 09, 2026 | 1.272 |
| September 08, 2026 | 1.319 |
| September 04, 2026 | 1.332 |
| September 03, 2026 | 1.303 |
| September 02, 2026 | 1.297 |
| September 01, 2026 | 1.243 |
| August 31, 2026 | 1.199 |
| August 28, 2026 | 1.187 |
| August 27, 2026 | 1.236 |
| August 26, 2026 | 1.243 |
| August 25, 2026 | 1.230 |
| August 24, 2026 | 1.224 |
| August 21, 2026 | 1.145 |
| Date | Value |
|---|---|
| August 20, 2026 | 1.137 |
| August 19, 2026 | 1.153 |
| August 18, 2026 | 1.116 |
| August 17, 2026 | 1.070 |
| August 14, 2026 | 1.061 |
| August 13, 2026 | 1.053 |
| August 12, 2026 | 1.097 |
| August 11, 2026 | 1.087 |
| August 10, 2026 | 1.080 |
| August 07, 2026 | 1.043 |
| August 06, 2026 | 1.060 |
| August 05, 2026 | 1.053 |
| August 04, 2026 | 1.050 |
| August 03, 2026 | 1.008 |
| July 31, 2026 | 0.9985 |
| July 30, 2026 | 1.025 |
| July 29, 2026 | 0.9846 |
| July 28, 2026 | 0.9873 |
| July 27, 2026 | 1.025 |
| July 24, 2026 | 1.009 |
| July 23, 2026 | 1.035 |
| July 22, 2026 | 1.028 |
| July 21, 2026 | 1.070 |
| July 20, 2026 | 1.056 |
| July 17, 2026 | 1.070 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.18 |
| Anika Therapeutics, Inc. | 1.986 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.570 |
Price to Book Value Related Metrics
| PS Ratio | 42.41 |
| Price | 16.30 |
| Earnings Yield | -10.09% |
| Market Cap | 995.57M |